Pharmacology

Pharmacology is the study of how chemical substances interact with living systems. If substances have medicinal properties, they are considered pharmaceuticals. The field encompasses drug composition and properties, interactions, toxicology, therapy, and medical applications and antipathogenic capabilities.

Pharmacology

Pharmacology is the study of the action of drugs on a biologic system. It incorporates components of medicine and biology, and how they interact with each other.

Carboplatin Pharmacology

Pharmacology of CAR-T Cells

What is Psychopharmacology?

What is in Silico?

Pharmacology of Paracetamol

Caffeine Pharmacology

Infliximab Pharmacology

Valproic Acid Pharmacology

Importance of Allostery in Pharmacology

Drug Metabolism

What is a Dose-Response Curve?

See more featured articles »

Pharmacokinetics

Hormone Pharmacology

Importance of Pharmacology in Dentistry

Pharmacist Career

Drug Excretion / Elimination

What Are Adaptogens-and Do They Actually Work?

Geriatric Pharmacology: Medication Management for an Aging Population

Haloperidol Pharmacology

Bottom-Up Approach Overview

Pharmacology of Cannabinoid Receptors

Nicotine Pharmacology

What is Toxicology?

Olanzapine Pharmacology

Morphine Pharmacology

Halicin: The AI-Discovered Antibiotic That Fights Superbugs

Metabolomics in Pharmacology

Opioid Pharmacology

What is Drug Absorption?

Psychopharmacology and Neuropsychopharmacology Research

What is Neuropharmacology?

Warfarin Pharmacology

Synthetic and Patented Cannabinoids

How Nasal Spray Use and Overuse Affects the Nose

What is Pharmacoepidemiology?

DNA and Technology

Celebrex (Celecoxib) Pharmacology

What is Efficacy?

How Can Biochemistry Practices be made Virtual?

Calcitonin Pharmacology

What is Pharmacodynamics?

Drug Distribution

What is Quantitative Systems Pharmacology (QSP) Modeling?

Latest Pharmacology News and Research

Study reveals a previously unknown ability of the brain to repair itself

The brain evidently can regenerate itself better than previously assumed after injuries or certain autoimmune diseases.

10 Aug 2026

Barrow launches clinical study of ibogaine for neurological recovery

Barrow Neurological Institute has received a $5-million grant from the Arizona Department of Health Services to conduct a Phase 1/2 clinical trial investigating ibogaine for treating people with neurological disorders such as traumatic brain injury (TBI).

6 Aug 2026

Texas A&M study links polyethylene microplastics to fatty liver disease

Microplastics have become nearly impossible to avoid. They have been detected in oceans, drinking water and even the human body, but scientists are still uncovering how they affect human health.

3 Aug 2026

New analytical strategies can measure thousands of gut microbial proteins

The trillions of microorganisms living in our intestine influence our health, from digestion and metabolism to immunity.

3 Aug 2026

New clinical framework maps pediatric Behçet’s spectrum disorders

Behçet's disease (BD) is a systemic vasculitis marked by recurrent oral and genital ulcers, but pediatric presentations are often partial or atypical, complicating diagnosis.

24 Jul 2026

Chinese researchers map epigenetic control of congenital heart defects

The findings have direct implications for clinical practice and future research. For genetic screening, the study provides a clear priority: CHD7 for outflow‑tract defects, CHD4 for chamber‑patterning anomalies, and CHD8 for ventricular dysfunction.

24 Jul 2026

Study uncovers biological differences behind co-occurring conditions of Down syndrome

In a groundbreaking new study published in Nature Communications, researchers from the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) discovered unique biological processes altered among individuals with Down syndrome who have different sets of co-occurring conditions.

23 Jul 2026

Former smokers retain lasting lung damage despite quitting

A new study by a team of McGill researchers could help explain why people who have quit smoking remain at elevated risk of lung disease long after their last cigarette.

22 Jul 2026

City of Hope launches trial to map how tumors change during immunotherapy resistance

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S. News & World Report, has opened an innovative Phase 2 clinical trial designed to map how tumors change as they begin to resist immunotherapy, treatment that improves the immune system's ability to fight disease.

21 Jul 2026

New peptide from cone snail venom shows promise for non-opioid pain relief

An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone snail venom which significantly reduced inflammation-induced pain in an animal model.

21 Jul 2026

Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference

Researchers compared semaglutide with liraglutide in 57,456 insured adults without recorded diabetes or cardiovascular disease who initiated formulations indicated for chronic weight management. Semaglutide users had a lower risk of incident diabetes, particularly beyond six months of follow-up, but limited cardiovascular events prevented a precise comparison of cardiovascular risk.

20 Jul 2026

Inflammatory messenger substance interferon-alpha can trigger Sjögren's syndrome

Findings from Bonn, Edinburgh and Newcastle could give a boost to pharmaceutical research.

20 Jul 2026

Mapping how influenza virus rewires human host cells

Researchers at EMBL Hamburg and collaborators at the Leibniz Research Institute for Molecular Pharmacology (FMP) have mapped how the influenza A virus rewires infected human cells in unprecedented detail.

20 Jul 2026

New approach enhances radiotherapy by disabling cancer's DNA repair machinery

Cancer treatments like radiation and chemotherapy work by doing one main thing: shredding the DNA of cancer cells so they can no longer multiply.

16 Jul 2026

Study highlights communication gaps between cancer survivors and providers on cannabis

For many cancer survivors, cannabis has become part of how they manage symptoms such as pain, nausea and anxiety.

16 Jul 2026

New drug candidate improves Parkinson's treatment in animal models

For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen.

15 Jul 2026

AI model predicts effective immunotherapy combinations for liver cancer

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular carcinoma (HCC) would most benefit from combination treatment using immunotherapy and a targeted therapy that blocks the growth signals that the tumor depends on.

15 Jul 2026